Text
In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.
Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.
Microbial differences may help to identify targets that could be modulated to mitigate health inequities.
The interplay between micronutrients and the microbiome is a significant factor in determining the risk of vitamin and mineral deficiencies, which has implications for global public health.
The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.
The findings suggest that lysine lactylation contributes to metabolic regulation in bacteria and that GNAT13 may limit sucrose-driven biofilm formation.
This study demonstrated fundamental mechanisms through which A. muciniphila and L. plantarum modify the gut microbiota and control immune responses in the SLE mouse model.
Industry
Sponsored by
Smiling ear to ear, supporting healthy teeth and mouth.
The findings suggest that the interplay between the respiratory tract microbiota, the levels of bacterial pathogens and specific clinical interventions is a key factor in determining the outcome of bacterial…
The findings of a recent study suggest that the composition of the mouth microbiota can be used to predict the recurrence of oral cancer.
